Li Shengtang, Shi Xuewen, Xu Bo, Wang Jian, Li Peng, Wang Xin, Lou Jinpeng, Li Ziyao, Yang Chengwei, Li Songkai, Zhen Ping
74713Lanzhou University Second Hospital, Lanzhou, China.
The 940th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, LanZhou, China.
J Biomater Appl. 2022 Apr;36(9):1676-1688. doi: 10.1177/08853282211064098. Epub 2022 Jan 11.
Currently, the treatment of osteomyelitis poses a great challenge to clinical orthopedics. The use of biodegradable materials combined with antibiotics provides a completely new option for the treatment of osteomyelitis. In this study, vancomycin hydrochloride (VANCO) loaded poly (lactic-co-glycolic acid) (PLGA) microspheres were prepared by a double emulsion solvent evaporation method, and the in vitro drug release behaviors of the drug loaded microspheres were explored after coating with different concentrations of silk fibroin (SF). Drug loading, encapsulation efficiency, Scanning electron microscopy, particle size analysis, Fourier transform infrared spectroscopy, hydrophilicity, in vitro drug release, and in vitro antibacterial activity were evaluated. The results showed that the drug loading of vancomycin loaded PLGA microspheres was (24.11 ±1.72)%, and the encapsulation efficiency was (48.21 ±3.44)%. The in vitro drug release indicated that the drug loaded microspheres showed an obvious initial burst release, and the drug loaded microspheres coated with SF could alleviate the initial burst release in varying degrees. It also can reduce the amount of cumulative drug release, and the effect of microspheres coated with 0.1% concentration of SF is the best. The time of in vitro drug release in different groups of drug loaded microspheres can be up to 28 days. The microspheres coated with (0.1%SF) or without (0%SF) SF showed a cumulative release of (82.50±3.51)% and (67.70±3.81)%,respectively. Therefore, the surface coating with SF of vancomycin loaded microspheres can alleviate the initial burst release, reduce the cumulative drug release, potentially prolong the drug action time, and improve the anti-infection effect.
目前,骨髓炎的治疗给临床骨科带来了巨大挑战。可生物降解材料与抗生素联合使用为骨髓炎的治疗提供了全新选择。本研究采用复乳溶剂挥发法制备了载盐酸万古霉素(VANCO)的聚乳酸-羟基乙酸共聚物(PLGA)微球,并探讨了用不同浓度丝素蛋白(SF)包衣后载药微球的体外释药行为。对载药量、包封率、扫描电子显微镜、粒径分析、傅里叶变换红外光谱、亲水性、体外释药及体外抗菌活性进行了评价。结果显示,载万古霉素PLGA微球的载药量为(24.11±1.72)%,包封率为(48.21±3.44)%。体外释药表明,载药微球呈现明显的初始突释现象,而用SF包衣的载药微球可不同程度缓解初始突释。它还能减少药物累积释放量,其中用0.1%浓度SF包衣的微球效果最佳。不同组载药微球的体外释药时间可达28天。用(0.1%SF)或不用(0%SF)SF包衣的微球累积释放率分别为(82.50±3.51)%和(67.70±3.81)%。因此,载万古霉素微球表面用SF包衣可缓解初始突释,减少药物累积释放,有可能延长药物作用时间并提高抗感染效果。